Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Maciej MachaczkaDivision of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, and Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, SwedenCorrespondence[email protected] [email protected]

Jan-Erik JohanssonDepartment of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden

Mats RembergerDivision of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden

Helene HallböökDepartment of Hematology, Uppsala University Hospital, Uppsala, Sweden

Claes MalmDepartment of Hematology, University Hospital of Linköping, Linköping, Sweden

Vladimir Lj LazarevicDepartment of Hematology, Skåne University Hospital and Lund University, Lund, Sweden

Anders WahlinDepartment of Radiation Sciences, University of Umeå, Umeå, Sweden

Hamdy OmarDivision of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, and Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden

Gunnar JuliussonDepartment of Hematology, Skåne University Hospital and Lund University, Lund, Sweden

Eva KimbyDivision of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, and Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden

Hans HägglundDivision of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, and Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, SwedenCorrespondence[email protected] [email protected]

show all

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Supplementary Tables I and II

Supplementary Tables I and II

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Supplementary Tables I and II

Supplementary Tables I and II

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date